The neurobiology of bipolar disorder

Economics of Neuroscience

Volumn 3, Issue 1, 2001, Pages 37-44

  Manji, H K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; AMPHETAMINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN MONOAMINE; CALCIUM; CLOZAPINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HOMOVANILLIC ACID; LITHIUM; MARCKS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUROLEPTIC AGENT; NORADRENALIN; PROTEIN BCL 2; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SEROTONIN; VALPROIC ACID;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CELL; CALCIUM SIGNALING; CELL SURVIVAL; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; DRUG ACTIVITY; DRUG EFFECT; ETIOLOGY; GENETIC ANALYSIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MANIC DEPRESSIVE PSYCHOSIS; MOLECULAR BIOLOGY; MONOAMINERGIC SYSTEM; MORPHOMETRICS; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; RODENT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

EID: 0035062520     PISSN: 15270815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Toward an integrated biological model of bipolar disorder
2. Biological rhythms in manic-depressive illness
3. Molecular mechanisms underlying mood-stabilization in manic-depressive illness: The phenotype challenge
4. Molecular clock genes in man and lower animals. Possible implications for circadian abnormalities in depression
5. Neuroendocrinology of mood disorders
6. Signaling: Cellular insights into the pathophysiology of bipolar disorder
7. Recent studies on norepinephrine systems in mood disorders
8. Monoaminergic mechanisms
9. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression
10. The neurochemistry of mood disorders clinical studies
11. PET imaging of serotonin 1A receptor binding in depression
12. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action
13. The dopamine hypothesis of schizophrenia and depression: Contradictions and speculations
14. Dopaminergic mechanisms in depression and mania
15. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder
16. The role of acetylcholine mechanisms in mood disorders
17. Lithium
18. Anti-bipolar therapy: Mechanism of action of lithium
19. The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
20. Stress and hippocampal plasticity
21. Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder
22. Signal transduction abnormalities in bipolar disorders
23. Lithium, carbamazepine and valproate in affective illness: Biochemical and neurobiological mechanisms
24. Guanine nucleotide binding (G) protein disturbances
25. Molecular machines integrate coincident synaptic signals
26. Emergent properties of networks of biological signaling pathways
27. Complexity in biological signaling systems
28. G proteins: Implications for psychiatry
29. Signal Transduction abnormalities in Bipolar Affective Disorder
30. s protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder
31. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains
32. Guanine nucleotide binding proteins in bipolar affective disorder: Effects of long-term lithium treatment
33. s in platelets of euthymic bipolar affective disorder patients
34. Abnormal G protein alpha(s)- and alpha(i2)-subunit mRNA expression in bipolar affective disorder
35. No abnormality in the gene for the G protein stimulatory α subunit in patients with bipolar disorder
36. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C
37. Protein kinase C and lipid signalling for sustained cellular responses
38. Protein kinase C
39. Protein kinase C: Structure, function and regulation
40. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder
41. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode
42. Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of bipolar disorder
43. Protein kinase C in the nervous system
44. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high dose tamoxifen
45. A preliminary investigation of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania
46. The calcium second messenger system in bipolar disorders: Data supporting new research directions
47. Neuroimaging studies of mood disorders
48. Neuroplasticity and cellular resilience in mood disorders [millennium article]
49. A molecular and cellular theory of depression
50. Neuronal plasticity and survival in mood disorders
51. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression
52. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
53. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?
54. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
55. Enhancement of hippocampal neurogenesis by lithium
56. Lithium-induced increase in human brain gray matter
57. Lithium Increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2′s neurotrophic effects?
58. Antidepressant treatments in the 21st century
59. Designing small-molecule switches for protein-protein interactions